These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 39422603)

  • 1. Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction.
    Jeong JC; Gelman AE; Chong AS
    Curr Opin Organ Transplant; 2024 Dec; 29(6):412-419. PubMed ID: 39422603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
    Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
    Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
    J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic effect of ischemia-reperfusion injury upon primary graft dysfunction and chronic lung allograft dysfunction in lung transplantation: evidence based on transcriptome data.
    Zheng XY; Huang H; Wei ZT; Yan HJ; Wang XW; Xu L; Li CH; Tang HT; Wang JJ; Yu ZW; Tian D
    Transpl Immunol; 2022 Apr; 71():101556. PubMed ID: 35202801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11b suppresses TLR activation of nonclassical monocytes to reduce primary graft dysfunction after lung transplantation.
    Querrey M; Chiu S; Lecuona E; Wu Q; Sun H; Anderson M; Kelly M; Ravi S; Misharin AV; Kreisel D; Bharat A; Budinger GRS
    J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35838047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction.
    Monticelli LA; Diamond JM; Saenz SA; Tait Wojno ED; Porteous MK; Cantu E; Artis D; Christie JD
    Am J Respir Crit Care Med; 2020 Jan; 201(1):63-72. PubMed ID: 31394048
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells.
    Siemeni T; Knöfel AK; Ius F; Sommer W; Salman J; Böthig D; Falk CS; Tudorache I; Haverich A; Warnecke G
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2528-2537. PubMed ID: 30955963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction.
    Dugger DT; Calabrese DR; Gao Y; Deiter F; Tsao T; Maheshwari J; Hays SR; Leard L; Kleinhenz ME; Shah R; Golden J; Kukreja J; Gordon ED; Singer JP; Greenland JR
    Front Immunol; 2021; 12():704172. PubMed ID: 34691018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between immune cells and the development of chronic lung allograft dysfunction.
    Ye D; Liu Q; Zhang C; Dai E; Fan J; Wu L
    Int Immunopharmacol; 2024 Aug; 137():112381. PubMed ID: 38865754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.
    Abbas AA; Diamond JM; Chehoud C; Chang B; Kotzin JJ; Young JC; Imai I; Haas AR; Cantu E; Lederer DJ; Meyer KC; Milewski RK; Olthoff KM; Shaked A; Christie JD; Bushman FD; Collman RG
    Am J Transplant; 2017 May; 17(5):1313-1324. PubMed ID: 27731934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients.
    Zhang D; Wang X; Du W; Qin W; Chen W; Zuo X; Li P
    Pulm Pharmacol Ther; 2023 Oct; 82():102243. PubMed ID: 37454870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction.
    Greenland JR; Guo R; Lee S; Tran L; Kapse B; Kukreja J; Hays SR; Golden JA; Calabrese DR; Singer JP; Wolters PJ
    J Heart Lung Transplant; 2023 Dec; 42(12):1700-1709. PubMed ID: 37648073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
    Calabrese DR; Ekstrand CA; Yellamilli S; Singer JP; Hays SR; Leard LE; Shah RJ; Venado A; Kolaitis NA; Perez A; Combes A; Greenland JR
    J Heart Lung Transplant; 2024 Jul; 43(7):1074-1086. PubMed ID: 38367738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis and management of chronic lung allograft dysfunction.
    Verleden GM; Hendriks JMH; Verleden SE
    Curr Opin Pulm Med; 2024 Jul; 30(4):377-381. PubMed ID: 38305383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector immune cells in chronic lung allograft dysfunction: A systematic review.
    Bos S; Filby AJ; Vos R; Fisher AJ
    Immunology; 2022 May; 166(1):17-37. PubMed ID: 35137398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of innate immunity in primary graft dysfunction after lung transplantation.
    Diamond JM; Wigfield CH
    Curr Opin Organ Transplant; 2013 Oct; 18(5):518-23. PubMed ID: 23995372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
    DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
    Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.